Spina Bifida Market Research Report- Forecast to 2023

Spina Bifida Market Research Report- Forecast to 2023

ID: MRFR/HC/4188-HCRR | November, 2018 | Region: Global | 85 pages | Half-Cooked Research Reports

Spina Bifida Market Research Report: By Type (Occulta, Closed Neural Tube Defects, Meningocele, Myelomeningocele), By Diagnosis (Blood Test, Ultrasound, Amniocentesis), Treatment (Medical Procedure, Surgeries), By End User – Global Forecast Till 2023


Market Scenario


Spina bifida is a congenital disorder that results in the malformation of the spinal cord. The condition is more common among Hispanics and whites, and the prevalence females are more likely to get affected than males.


On considering historical prevalence data of spina bifida in northeast China, during 2006-2015, it is found that a total of 2,029 cases of spina bifida were identified from 3,248,954 live births i.e. 6.25/10,000 live births. The disease is found to be highly prevalent in Chaoyang, Fuxin, and Huludao cities of China. According to the 2013 study conducted by Healthcare Cost and Utilization Project, hospitalization cost related to spina bifida was more than USD 600 million in 2013 for people of all ages.


It is noted that rising technological advancements is the key factor driving the spina bifida market. With the rising awareness about the disease, market players are coming up with innovations owing to technological advancements. For instance, in Nov 2015, B. Braun Melsungen AG announced the launch of Ster-ASSIST Sterile Peripheral IV Catheter Insertion Kit. In the same year, Medtronic acquired Twelve, Inc., a developer of trans-catheter mitral valve replacement device.


Various other factors such as growing awareness, increased incidence of spina bifida, related complications, unmet medical needs, improving regulatory framework, increasing adoption rate, increasing government assistance, and rising funding and reimbursement are continuously contributing to the growth of the global spina bifida market.


Despite these drivers, there are some issues associated with spina bifida market. The cost of treatment, side-effects of surgeries, and poor healthcare system in low and middle-income countries may hinder the growth of the market to an extent.


It is estimated that the spina bifida market is expected to grow at a CAGR 8.0% during the forecast period of 2017-2023.


Research Methodology


 spina bifida


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


Segmentation


The global spina bifida market is segmented on the basis of type, diagnosis, treatment, and end user.


On the basis of the type, the market is classified as occulta, closed neural tube defects, meningocele, and myelomeningocele.


On the basis of the diagnosis, the market is classified as blood tests, ultrasound, amniocentesis, and others. The blood tests segment is further classified as maternal serum alpha-fetoprotein (MSAFP) test, test to confirm high AFP levels, and other blood tests.


On the basis of the treatment, the market is classified as medical procedure, surgery, oral medications, and others. The medical procedure is further segmented into urinary catheterization, urinary diversion, and enema. The surgery is further segmented into spine surgery, fetal endoscopic surgery, spinal fusion, suprapubic cystostomy, and caesarean section. The oral medications is further segmented into antibiotics, and others.


On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.


Regional Analysis


The Americas dominate the spina bifida market owing to the rising occurrence of spina bifida in this region, and technological advancements. According to the statistics suggested by Centers for Disease Control and Prevention (CDC), around 1,500 babies are born with spina bifida every year in the United States. It is also reported that Hispanic women are the most vulnerable population for this disease as compared to non-Hispanic black or non-Hispanic white women.


Europe holds the second position in the spina bifida market. It is expected that the government support towards research & development expenditure, and amendments in reimbursement policies in the healthcare is likely to drive the European spina bifida market.


Asia Pacific is the fastest growing spina bifida market owing to a huge patient pool and development in healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion i.e. 3.6% higher than the expenditure of 2014-2015.


The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.


Key Players


Some of key the players in the global spina bifida market are B. Braun Melsungen AG, Boston Scientific, C.B. Fleet, C.R. Bard, Inc., Coloplast A/S, ConvaTec Group plc, Cook Medical, Covidien Private Ltd., Dynarex Corporation, Ethicon, Fujifilm, Hollister Incorporated, KARL STORZ, Medline Industries, Medtronic plc, Olympus, Pacific Hospital Supply Co., Ltd., Smith & Nephew, Stryker, Teleflex Incorporation, Wellspect Healthcare, and others.

Table of Contents:





Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Spina Bifida Market, by Type

6.1 Introduction

6.2 Occulta

6.2.1 Market Estimates & Forecast, 2017 – 2023

6.3 Closed Neural Tube Defects

6.3.1 Market Estimates & Forecast, 2017 – 2023

6.4 Meningocele

6.4.1 Market Estimates & Forecast, 2017 – 2023

6.5 Myelomeningocele

6.5.1 Market Estimates & Forecast, 2017 – 2023

Chapter 7. Global Spina Bifida Market, by Diagnosis

7.1 Introduction

7.2 Blood Tests

7.2.1 Market Estimates & Forecast, 2017 – 2023

7.3 Ultrasound

7.3.1 Market Estimates & Forecast, 2017 – 2023

7.4 Amniocentesis

7.4.1 Market Estimates & Forecast, 2017 – 2023

7.5 Others

7.5.1 Market Estimates & Forecast, 2017 – 2023



Chapter 8. Global Spina Bifida Market, by treatment

8.1 Introduction

8.2 Medical Procedure

8.2.1 Market Estimates & Forecast, 2017 – 2023

8.3 Surgery

8.3.1 Market Estimates & Forecast, 2017 – 2023

8.4 Oral Medications

8.4.1 Market Estimates & Forecast, 2017 – 2023

8.5 Others

8.5.1 Market Estimates & Forecast, 2017 – 2023

Chapter 9. Global Spina Bifida Market, by End User

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2017 – 2023

9.3 Clinics

9.3.1 Market Estimates & Forecast, 2017 – 2023

9.4 Diagnostic Centers

9.4.1 Market Estimates & Forecast, 2017 – 2023

9.5 Drug Stores

9.5.1 Market Estimates & Forecast, 2017 – 2023

9.6 Pharmacies

9.6.1 Market Estimates & Forecast, 2017 – 2023

9.7 Others

9.7.1 Market Estimates & Forecast, 2017 – 2023

Chapter 10. Global Spina Bifida Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 B. Braun Melsungen AG

12.1.1 Company Overview

12.1.2 Types Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Boston Scientific

12.2.1 Company Overview

12.2.2 Types Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Cook Medical

12.3.1 Company Overview

12.3.2 Types Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Ethicon

12.4.1 Company Overview

12.4.2 Types/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 KARL STORZ

12.5.1 Company Overview

12.5.2 Types Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 KARL STORZ Private Limited

12.6.1 Company Overview

12.6.2 Types Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 MEDLINE INDUSTRIES

12.7.1 Overview

12.7.2 Types Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Spina Bifida industry

Chapter 14 Appendix



LIST OF TABLES



Table 1 Spina Bifida Industry Synopsis, 2017 – 2023

Table 2 Spina Bifida Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Spina Bifida Market by Region, 2017 – 2023, (USD Million)

Table 4 Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 5 Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 6 Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 7 Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 8 North America Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 9 North America Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 10 North America Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 11 North America Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 12 US Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 13 US Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 14 US Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 15 US Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 16 Canada Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 17 Canada Spina Bifida market by Diagnosis, 2017 – 2023, (USD Million)

Table 18 Canada Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 19 Canada Spina Bifida market by End Users, 2017 – 2023, (USD Million)

Table 20 South America Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 21 South America Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 22 South America Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 23 South America Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 24 Europe Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 25 Europe Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 26 Europe Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 27 Europe Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 28 Western Europe Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 29 Western Europe Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 30 Western Europe Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 31 Western Europe Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 32 Eastern Europe Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 33 Eastern Europe Spina Bifida market by Diagnosis, 2017 – 2023, (USD Million)

Table 34 Eastern Europe Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 35 Eastern Europe Spina Bifida Market by End Users, 2017 – 2023, (USD Million)

Table 36 Asia Pacific Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 37 Asia Pacific Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 38 Asia Pacific Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 39 Asia Pacific Spina Bifida market by End Users, 2017 – 2023, (USD Million)

Table 40 The Middle East & Africa Spina Bifida Market by Type, 2017 – 2023, (USD Million)

Table 41 The Middle East & Africa Spina Bifida Market by Diagnosis, 2017 – 2023, (USD Million)

Table 42 The Middle East & Africa Spina Bifida Market by Treatment, 2017 – 2023, (USD Million)

Table 43 The Middle East & Africa Spina Bifida market by End Users, 2017 – 2023, (USD Million)



LIST OF FIGURES



Figure 1 Research Process

Figure 2 Segmentation for Spina Bifida Market

Figure 3 Segmentation Market Dynamics for Spina Bifida Market

Figure 4 Global Spina Bifida market Share, by Type 2016

Figure 5 Global Spina Bifida market Share, by Diagnosis 2016

Figure 6 Global Spina Bifida market Share, by Treatment 2016

Figure 7 Global Spina Bifida market Share, by End Users, 2016

Figure 8 Global Spina Bifida market Share, by Region, 2016

Figure 9 North America Spina Bifida market Share, by Country, 2016

Figure 10 Europe Spina Bifida market Share, by Country, 2016

Figure 11 Asia Pacific Spina Bifida market Share, by Country, 2016

Figure 12 Middle East & Africa Spina Bifida market Share, by Country, 2016

Figure 13 Global Spina Bifida market: Company Share Analysis, 2016 (%)

Figure 14 B. Braun Melsungen AG : Key Financials

Figure 15 B. Braun Melsungen AG Segmental Revenue

Figure 16 B. Braun Melsungen AG : Geographical Revenue

Figure 17 Boston Scientific: Key Financials

Figure 18 Boston Scientific: Segmental Revenue

Figure 19 Boston Scientific: Geographical Revenue

Figure 20 Cook Medical: Key Financials

Figure 21 Cook Medical: Segmental Revenue

Figure 22 Cook Medical: Geographical Revenue

Figure 23 Ethicon: Key Financials

Figure 24 Ethicon: Segmental Revenue

Figure 25 Ethicon: Geographical Revenue

Figure 26 KARL STORZ: Key Financials

Figure 27 KARL STORZ: Segmental Revenue

Figure 28 KARL STORZ Geographical Revenue

Figure 29 KARL STORZ Private Limited: Key Financials

Figure 30 KARL STORZ Private Limited: Segmental Revenue

Figure 31 KARL STORZ Private Limited: Geographical Revenue

Figure 32 MEDLINE INDUSTRIES: Key Financials

Figure 33 MEDLINE INDUSTRIES: Segmental Revenue

Figure 34 MEDLINE INDUSTRIES: Geographical Revenue